Insider · CIK 0001109753

BELBEL CAESAR J

Reports to the SEC for 2 companies · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001109753

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−21.7K sh	$4.14	−$89.7K	207,434
2017-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−31.5K sh	$4.14	−$130K	229,101
2017-12-29	TCRTAlaunos Therapeutics, Inc.A Award	COO, CLO, and Secretary	AAward	+87K sh	—	—	260,551
2017-06-01	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−16.7K sh	$6.11	−$102K	173,551
2016-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−21.7K sh	$5.35	−$116K	190,217
2016-12-30	TCRTAlaunos Therapeutics, Inc.A Award	COO, CLO, and Secretary	AAward	+94.4K sh	—	—	211,884
2016-06-01	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−6,667 sh	$7.74	−$51.6K	117,534
2015-12-31	TCRTAlaunos Therapeutics, Inc.A Award	COO, CLO, and Secretary	AAward	+65K sh	—	—	124,201
2015-11-19	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	COO, CLO, and Secretary	MExercise/Conversion	+153K sh	$2.30	+$353K	212,534
2015-11-19	TCRTAlaunos Therapeutics, Inc.S Sale	COO, CLO, and Secretary	SSale	−153K sh	$12.84	−$1.97M	59,201
2015-11-19	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	COO, CLO, and Secretary	MExercise/Conversion	−153K sh	—	—	76,667
2015-06-01	TCRTAlaunos Therapeutics, Inc.A Award	COO, CLO, and Secretary	AAward	+50K sh	—	—	59,201
2015-02-22	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−14.6K sh	$10.06	−$147K	9,201
2014-12-31	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	COO, CLO, and Secretary	AAward	+175K sh	—	—	175,000
2014-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−7,192 sh	$5.03	−$36.2K	23,802
2014-02-22	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−14.6K sh	$4.40	−$64.2K	30,994
2013-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−7,193 sh	$4.34	−$31.2K	45,594
2013-12-31	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	COO, CLO, and Secretary	AAward	+150K sh	—	—	150,000
2013-06-27	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	COO, CLO, and Secretary	AAward	+230K sh	—	—	230,000
2013-02-22	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−5,400 sh	$4.50	−$24.3K	52,787
2012-12-31	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	COO, CLO, and Secretary	AAward	+150K sh	—	—	150,000
2012-12-31	TCRTAlaunos Therapeutics, Inc. · Common Stock (tax withholding right)F Tax Payment	COO, CLO, and Secretary	FTax Payment	−4,909 sh	—	—	0
2012-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	COO, CLO, and Secretary	FTax Payment	−2,284 sh	$4.21	−$9,615.64	58,187
2012-02-22	TCRTAlaunos Therapeutics, Inc.A Award	COO, CLO, and Secretary	AAward	+43.8K sh	—	—	65,380
2011-12-30	TCRTAlaunos Therapeutics, Inc.A Award	COO, CLO, and Secretary	AAward	+21.6K sh	—	—	21,578
2011-09-06	TCRTAlaunos Therapeutics, Inc. · Stock Options (right to buy)A Award	COO, CLO, and Secretary	AAward	+200K sh	—	—	200,000
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−75K sh	$11.61	−$871K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−1,059 sh	$26.79	−$28.4K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−12K sh	$15.77	−$189K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−75K sh	$18.07	−$1.36M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−90K sh	$17.63	−$1.59M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−4,545 sh	$19.27	−$87.6K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−45K sh	$15.01	−$675K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−65K sh	$21.22	−$1.38M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−50K sh	$13.05	−$653K	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	EVP, Chief Legal Officer	DDisposition to Issuer	−75K sh	$13.46	−$1.01M	0
2010-12-22	CLINICAL DATA INCStock Option (Right to Buy)A Award	EVP, Chief Legal Officer	AAward	+75K sh	—	—	75,000
2009-12-21	CLINICAL DATA INCStock Option (Right to Buy)A Award	EVP, Chief Legal Officer	AAward	+75K sh	—	—	75,000
2008-12-22	CLINICAL DATA INCStock Option (Right to Buy)A Award	EVP, Chief Legal Officer	AAward	+65K sh	—	—	65,000
2007-06-14	CLINICAL DATA INCStock Option (Right to buy)A Award	EVP, Chief Legal Officer	AAward	+30K sh	—	—	30,000
2006-06-22	CLINICAL DATA INCStock Option (Right to buy)A Award	EVP, Chief Legal Officer	AAward	+3,030 sh	—	—	3,030

Recent filings

Accepted (ET)
Jan 34
BELBEL CAESAR J0001209191-18-000972
SEC(opens sec.gov)
Jun 54
ZIOPHARM ONCOLOGY INC0001209191-17-037731
SEC(opens sec.gov)
Jan 44
ZIOPHARM ONCOLOGY INC0001209191-17-000982
SEC(opens sec.gov)
Jun 34
ZIOPHARM ONCOLOGY INC0001209191-16-125621
SEC(opens sec.gov)
Jan 54
ZIOPHARM ONCOLOGY INC0001209191-16-088708
SEC(opens sec.gov)
Nov 234
ZIOPHARM ONCOLOGY INC0001209191-15-081865
SEC(opens sec.gov)
Jun 24
ZIOPHARM ONCOLOGY INC0001209191-15-049082
SEC(opens sec.gov)
Feb 244
ZIOPHARM ONCOLOGY INC0001209191-15-017929
SEC(opens sec.gov)
Jan 24
ZIOPHARM ONCOLOGY INC0001209191-15-000204
SEC(opens sec.gov)
Feb 254
ZIOPHARM ONCOLOGY INC0001209191-14-014090
SEC(opens sec.gov)
Jan 34
ZIOPHARM ONCOLOGY INC0001209191-14-000727
SEC(opens sec.gov)
Jun 284
ZIOPHARM ONCOLOGY INC0001209191-13-034006
SEC(opens sec.gov)
Feb 254
ZIOPHARM ONCOLOGY INC0001209191-13-011183
SEC(opens sec.gov)

Companies

Address

C/O CLINICAL DATA, INC. ONE GATEWAY CENTER, SUITE 702

NEWTON, MA, 02458